# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001566044-21-000034
Filing Date
2021-08-12
Accepted
2021-08-12 08:47:15
Documents
69
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | vyne-20210630.htm iXBRL | 10-Q | 1255244
2 | EX-10.1 | ex101zeronda-executiveempl.htm | EX-10.1 | 118061
3 | EX-31.1 | vyne-20210630xexx311.htm | EX-31.1 | 9709
4 | EX-31.2 | vyne-20210630xexx312.htm | EX-31.2 | 9703
5 | EX-32.1 | vyne-20210630xexx321.htm | EX-32.1 | 5282
6 | EX-32.2 | vyne-20210630xexx322.htm | EX-32.2 | 5273
12 |  | image_0a.jpg | GRAPHIC | 33776
| Complete submission text file | 0001566044-21-000034.txt |  | 6523536

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | vyne-20210630.xsd | EX-101.SCH | 44300
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | vyne-20210630_cal.xml | EX-101.CAL | 67575
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | vyne-20210630_def.xml | EX-101.DEF | 272754
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | vyne-20210630_lab.xml | EX-101.LAB | 593256
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | vyne-20210630_pre.xml | EX-101.PRE | 407104
13 | EXTRACTED XBRL INSTANCE DOCUMENT | vyne-20210630_htm.xml | XML | 898253

Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 211165619
SIC: 2834 Pharmaceutical Preparations